Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
Allison H. Scotch(Mayo Clinic in Arizona), Robert Peter Gale(Imperial College London), Jean‐Jacques Kiladjian(Délégation Paris 5), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Zhijian Xiao(Institute of Hematology & Blood Diseases Hospital), Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), Xiujuan Sun(Chinese Academy of Sciences), Heike L. Pahl(University Medical Center Freiburg), Robyn M. Scherber(Blueprint Medicines (United States)), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Andreas Reiter(Heidelberg University), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Maria Luisa Ferrari(University of Bergamo), Harry C. Schouten, Norman Maldonado(University of Puerto Rico System), Heidi Kosiorek(Mayo Clinic in Florida), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Jan Samuelsson(Karolinska University Hospital), Peter Johansson(Linköping University), Konstanze Döhner(University Hospital Ulm), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Peter A.W. te Boekhorst(Erasmus MC), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tiziano Barbui(University of Bergamo), Gabriel Étienne(Institut Bergonié), Karin Bonatz(Centre Hospitalier Universitaire de Grenoble), Chiara Paoli(University of Genoa), Suzan Commandeur(Leiden University), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Sonja Zweegman(Vrije Universiteit Amsterdam), Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), Yue Zhang(Soochow University), Junqing Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zefeng Xu(Henan University), Peihong Zhang(Tongji University), Jean‐Yves Cahn(Université Grenoble Alpes), Françoise Boyer(Centre Hospitalier Universitaire d'Angers), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Ana Kerguelen Fuentes(Centre Hospitalier Universitaire de Grenoble), Lydia Roy(Centre Hospitalier Universitaire de Poitiers)
Cited by 27
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k